Innova Captab enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024
6,007———
44.544.515.511.7
344344338245
6,306———
299299323233
₹1,101.99———
1,4251,4251,2981,076
24.1%24.1%26.1%22.8%
0.05×———
3.60×———
24.30×———
29.52×———
134.54×———
Reference items — trailing FY values
1,7491,6301,2441,081
259243186154
214198161138
—11563.8146
46.946.9−109−141
—42.9−109−145
—68.3172287
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

INNOVACAP₹1,049.70

Innova Captab Limited

· Pharma & Health
₹ CrorePeersMOREPENLABIOLCPFDCSENORESSANOFIORCHPHARMAGUJTHEMRPGLIFEMcap ₹6,007 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization———6,006.9
- Cash, Equiv & ST Investments11.715.544.544.5
+ Total Debt245.1338.1343.7343.7
Enterprise Value———6,306.1
Net Debt (memo)233.4322.6299.2299.2
EV per Share———1,101.99
Total Capital1,076.01,297.51,425.21,425.2
Total Debt/Total Capital22.7826.0624.1224.12
Total Debt/EV———0.05
EV/Sales———3.60
EV/EBITDA———24.30
EV/EBIT———29.52
EV/Free Cash Flow———134.54
Reference Items — Trailing FY Values
Sales1,081.31,243.71,630.01,749.3
EBITDA154.5186.2242.9259.5
EBIT138.5161.4197.7213.6
Operating Cash Flow146.363.8115.2—
Free Cash Flow-141.0-108.746.946.9
FCFF (free cash flow to the firm)-145.1-109.142.9—
Capital Expenditure287.4172.568.3—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.